BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Rich Pharma Retains Contract Research Organization, CMIC, To Manage Upcoming Phase 1/2 Clinical Trial For Its Acute Myelocytic Leukemia (AML) And Myelodysplastic Syndrome (MDS) Drug In Thailand

  April 4, 2016

   · 

  2 min read
• Policy

  Samsung Bioepis Brings in Lawyers to Sue AbbVie in Biosimilars Push

  April 4, 2016

   · 

  1 min read
• Drug Development

  Amgen, UCB Group’s Romosozumab Tops Teriparatide in Phase III Osteoporosis Study

  April 4, 2016

   · 

  16 min read
• Policy

  FDA Extends Action Date for Progenics, Valeant’s NDA for Oral RELISTOR

  April 4, 2016

   · 

  4 min read
• BioMidwest

  St. Jude Medical Cardiomems HF System Prompts Changes That Improve Heart Failure Management And Reduce Hospitalizations

  April 4, 2016

   · 

  5 min read
• Business

  LiveLeaf Licenses Technology To InQpharm For Its Animal Health Division

  April 4, 2016

   · 

  4 min read
• Business

  Adherium Appoints Senior Executive To Lead Market Expansion And Establishes European Operations

  April 4, 2016

   · 

  3 min read
• Drug Development

  ORYX Enrolls First Patients In A Dose-Escalating Phase I/IIa Pilot Study With Oncolytic Virus Parvoryx To Treat Metastatic Pancreatic Cancer

  April 4, 2016

   · 

  2 min read
• Pharm Country

  China’s Dalian Fusheng Pharmaceutical Company Co., Ltd. Sponsors Fellowship In Geriatric Medicine Through The Milstein Medical Asian American Partnership (MMAAP) Foundation

  April 4, 2016

   · 

  3 min read
• Drug Development

  Alexion Release: Data Presented At ENDO 2016 Show Sustained Improvements In Survival Rates, Bone Healing, Respiratory Support And Physical Function In Children With Hypophosphatasia (HPP) Receiving Long-Term Treatment With Strensiq (Asfotase Alfa)

  April 4, 2016

   · 

  15 min read